Related Experiment Videos
Proton therapy in ophthalmology: status report and problems encountered
P Chauvel1, N Iborra-Brassart, A Courdi
1Centre Antoine-Lacassagne CAL, Cyclotron Biomédical, Nice, France.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique
|January 1, 1996
Summary
Proton therapy effectively treated 600 ocular tumor patients between 1991 and 1995. This review covers initial challenges in proton therapy for eye tumors, focusing on dose distribution accuracy.
Area of Science:
- Radiation Oncology
- Medical Physics
- Ophthalmology
Background:
- Proton therapy offers precise radiation delivery for tumors.
- Ocular tumors present unique challenges due to proximity to sensitive structures.
- The Centre Antoine-Lacassagne established a proton therapy facility for ocular tumors in 1991.
Purpose of the Study:
- To review the initial 4 years of ocular tumor treatment using proton therapy.
- To identify and analyze challenges impacting dose distribution accuracy and reliability.
Main Methods:
- Retrospective analysis of 600 ocular tumor cases treated from June 1991 to October 1995.
- Identification of technical and clinical issues encountered during treatment planning and delivery.
Main Results:
- A total of 600 patients with ocular tumors were treated.
- Key challenges affecting dose distribution were documented.
- The study provides an overview of early clinical experience.
Conclusions:
- Proton therapy is a viable treatment for ocular tumors.
- Addressing identified challenges is crucial for optimizing treatment outcomes.
- Continuous evaluation of proton therapy techniques is essential for improving accuracy and reliability.